Median salary
$186,375
per year · annualized USD
Typical range
$169.5k – $192.8k
25th–75th percentile
Disclosing pay
77.8%
28 of 36 roles
Live roles
36
open right now
Regional Medical Scientific Director (Medical Science Liaison) - Cardiovascular & Metabolism (Northern California)
88-50101989 Therapeutic Area Pipeline Medical Science Liaison
Senior Medical Science Liaison - Northern California & Hawaii - Oncology-Lung Pan Tumor
Oncology Medical Science Liaison
Senior Medical Science Liaison, Rheumatology - Sierra/Rockies
Senior Medical Science Liaison, Rheumatology - Southern California Territory
Senior Medical Science Liaison, Rheumatology - Pacific Northwest
Sr. Manager, Medical Affairs - Evidence Generation and Data Insights
| Company | Median | Roles |
|---|---|---|
Johnson & Johnson
|
$186,375 | 4 |
| BI Biogen | $192,750 | 3 |
Roche
|
$250,753 | 2 |
Gilead Sciences
|
$168,090 | 2 |
Eisai
|
$166,850 | 2 |
MSD
|
$245,550 | 1 |
Collegium Pharmaceutical
|
$207,500 | 1 |
Insulet
|
$195,100 | 1 |
See every Medical Affairs role
Browse the live listings, or save this search and get alerted the moment a new one posts.
The median salary for Medical Affairs roles in California is $186,375 per year. Most pay falls between $169,523 (25th percentile) and $192,750 (75th percentile), with the broader 10th–90th percentile band running from $164,533 to $214,370.
These figures are computed live from 36 active Medical Affairs roles in California on JobsRadar, of which 28 (77.8%) publish a salary range. Pay is normalized to annualized USD so roles can be compared on equal terms; the highest-paying roles listed above show their original posted currency. Numbers refresh every few hours as new roles are posted and older ones close.
Employers currently hiring well-paid Medical Affairs roles in California include MSD, Roche, Inizio Engage and Johnson & Johnson.
Salary transparency varies by employer and region, so the disclosing share above reflects only roles that publish pay — not every open position. Use it as a directional benchmark rather than an exact offer.